Previous research showed that in AD mouse models, the complement effector protein C1q can promote the activation of C3 (including C3a and C3b) and microglia, leading to the release of inflammatory factors and cytotoxins and the damage of neurons and synapses, resulting in synapse losses [107]. This evidence concerns the gene C3 and Alzheimer disease.